Mammography Biopsy Chair Market Analysis & Forecast: 2026-2033

Mammography Biopsy Chair Market Size and Forecast – 2026 to 2033

The Mammography Biopsy Chair Market is estimated to be valued at USD 95.7 Mn in 2026 and is expected to reach USD 149.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.

Key Takeaways

• By Product Type, Electric hold the largest market share of 52.2% in 2026 owing to the need for precise patient positioning.
• By Feature, Reclining acquired the prominent market share of 53.3% in 2026 owing to its improved procedural precision.
• By End User, Hospitals and Clinics expected to hold the largest market share of 37.8% in 2026 owing to its high patient volume and centralized care.
• By Region, North America dominates the overall market with an estimated share of 37.4% in 2026 owing to the high adoption of advanced imaging technologies.

Market Overview

The Mammography Biopsy Chair Market continues to expand as the rising prevalence of Breast Cancer drives demand and healthcare systems place greater emphasis on early detection and minimally invasive diagnostic procedures. Healthcare providers increasingly adopt advanced, ergonomic chairs to improve patient comfort and ensure precise positioning during image-guided biopsies. Ongoing technological advancements, including integration with digital mammography and 3D imaging systems, further accelerate growth. Moreover, the expansion of hospitals, diagnostic centers, and specialized breast care clinics, especially in emerging regions, actively boosts demand for modern biopsy chair solutions.

Current Events and their Impact on the Mammography Biopsy Chair Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights 

To learn more about this report, Download Free Sample

Mammography Biopsy Chair Market Insights, By Product Type: Electric contribute the highest share of the market owing to its workflow efficiency for clinicians.

Electric hold the largest market share of 52.2% in 2026. The electric segment in the Mammography Biopsy Chair Market is gaining momentum as healthcare providers address the growing need for accurate positioning and smoother workflows during diagnostic procedures related to Breast Cancer. Clinicians use motorized adjustments to achieve precise alignment with minimal manual effort, which improves efficiency and reduces procedure time. These chairs enhance patient comfort by offering customizable positioning, especially during sensitive procedures. Additionally, healthcare facilities are increasingly adopting advanced imaging systems and prioritizing patient-centric care, which drives investment in electric biopsy chairs.

Mammography Biopsy Chair Market Insights, By Feature: Reclining contributes the highest share of the market owing to its workflow and operational efficiency.

Reclining acquired the prominent market share of 53.3% in 2026. The reclining segment in the Mammography Biopsy Chair Market is expanding as healthcare providers focus on patient comfort, procedural accuracy, and workflow efficiency. Patients use reclining chairs to stay relaxed during biopsies, reducing movement and improving precision. Clinicians adjust the chairs to support minimally invasive procedures and optimize access for image-guided diagnostics. Hospitals and clinics are increasingly adopting reclining chairs to enhance patient experience, integrate with advanced imaging systems, and streamline operations, addressing the growing demand for ergonomic and versatile biopsy solutions.

Mammography Biopsy Chair Market Insights, By End User: Hospital and Clinics contribute the highest share of the market owing to its advanced diagnostic infrastructure in hospitals.

Hospitals and Clinics expected to hold the largest market share of 37.8% in 2026. The hospitals and clinics segment in the Mammography Biopsy Chair Market is growing as healthcare providers handle a rising number of patients undergoing diagnostic procedures for Breast Cancer and seek reliable, high-performance equipment. These facilities prioritize efficient workflows, leading them to adopt advanced biopsy chairs that enable quick and accurate procedures. Ongoing expansion of healthcare infrastructure and the emergence of specialized imaging and breast care centers further drive demand. Additionally, providers focus on enhancing patient experience and clinical outcomes, which increases investment in modern biopsy chair solutions.

Regional Insights 

To learn more about this report, Download Free Sample

North America Mammography Biopsy Chair Market Trends

North America dominates the overall market with an estimated share of 37.40% in 2026. The North America Mammography Biopsy Chair Market is evolving as healthcare providers adopt continuous technological innovations and prioritize early diagnosis of Breast Cancer. Facilities increasingly use digitally integrated and electrically operated chairs to enhance procedural accuracy and patient handling. Providers are also shifting toward outpatient imaging centers to offer more convenient and cost-effective care. Meanwhile, manufacturers focus on ergonomic designs and advanced features, supporting the region’s emphasis on patient comfort, clinical efficiency, and modernization of diagnostic environments.

Asia Pacific Mammography Biopsy Chair Market Trends

The Asia Pacific Mammography Biopsy Chair Market is growing as healthcare providers address the rising incidence of Breast Cancer and promote early detection awareness. Hospitals and diagnostic centers are increasingly adopting electric and ergonomically designed chairs to enhance patient comfort and ensure precise procedures. Expanding healthcare infrastructure and the establishment of specialized breast care clinics are driving faster adoption. At the same time, providers are demanding modern imaging solutions and technologically advanced equipment, shaping the region’s evolving market trends.

United States Mammography Biopsy Chair Market Trends

The United States Mammography Biopsy Chair Market is growing as healthcare providers focus on early detection and precise Breast Cancer diagnostics. Hospitals and specialized imaging centers are adopting electric and ergonomically designed chairs to enhance procedural efficiency and patient comfort. Providers are also investing in advanced diagnostic technologies, including digital mammography and 3D imaging systems, to support these improvements. At the same time, expanding outpatient clinics and breast care centers are driving demand for modern biopsy chairs that deliver accuracy, safety, and patient-centered design nationwide.

Japan Mammography Biopsy Chair Market Trends

The Japan Mammography Biopsy Chair Market is growing as healthcare providers focus on early Breast Cancer detection and minimally invasive diagnostic procedures. Hospitals and specialized imaging centers are increasingly using electric and ergonomically designed chairs to enhance patient comfort and ensure procedural accuracy. Providers are investing in advanced imaging technologies, including digital and 3D mammography systems, to support this growth. At the same time, expanding outpatient clinics and breast care centers, combined with a focus on efficiency and patient-centered care, are driving demand for modern, technologically advanced biopsy chairs throughout Japan.

Mammography Biopsy Chair Market Trend

Adoption of Electric and Motorized Chairs

Healthcare facilities are increasingly shifting from manual to electric or motorized biopsy chairs to improve procedural accuracy and efficiency. These chairs allow smooth adjustments for height, tilt, and rotation, enhancing patient comfort while reducing clinician effort. The trend reflects growing emphasis on ergonomics and workflow optimization in hospitals, outpatient clinics, and specialized breast care centers. Providers prefer chairs with programmable positions that support complex biopsy angles and image-guided procedures.

Integration with Advanced Imaging Technologies

Modern mammography biopsy chairs are evolving to integrate seamlessly with advanced imaging systems such as 3D mammography, digital breast tomosynthesis, and AI-assisted diagnostics. This trend enables precise targeting during biopsies and reduces repeat procedures. Facilities increasingly demand chairs compatible with imaging software, allowing synchronized movements, real-time adjustments, and streamlined workflows. Such integration supports accurate diagnoses, enhances efficiency, and aligns with the growing focus on minimally invasive breast procedures.

Mammography Biopsy Chair Market Opportunity

Rising Breast Cancer Screening Programs

Governments and healthcare organizations are increasingly promoting early detection of Breast Cancer through nationwide screening initiatives. This creates opportunities for hospitals, clinics, and diagnostic centers to adopt advanced biopsy chairs that support high patient volumes and precise procedures. Providers can leverage these programs to expand service offerings, improve procedural efficiency, and meet the growing demand for minimally invasive, image-guided biopsies in both urban and rural healthcare settings.

Market Report Scope 

Mammography Biopsy Chair Market News

In January 2026, iSono Health announced the commercial launch of ATUSA, an FDA-cleared wearable platform for automated 3D quantitative breast ultrasound. Built for routine clinical use, it expands access to high-quality imaging by removing dependence on scarce sonographers and expensive equipment, targeting the $14B U.S. breast imaging market.

In February 2025, SOPHiA GENETICS, a leader in AI-driven healthcare, announced a major milestone in the global adoption of its cancer testing solutions, MSK-ACCESS and MSK-IMPACT, both powered by SOPHiA DDM. These liquid biopsy and solid tumor applications have been adopted by 37 leading institutions, including top researchers and key opinion leaders worldwide.

Analyst Opinion (Expert Opinion)

• Current clinical utilization of mammography‑guided biopsies underscores the critical role of specialized positioning equipment: mammography guides approximately 90 % of all breast biopsies, highlighting how foundational accurate patient alignment is to diagnostic workflows. Chairs that support stable positioning directly influence procedural quality, particularly for stereotactic interventions that constitute roughly 40 % of suspicious mammographic findings requiring tissue sampling.
• Healthcare providers are increasingly linking investment decisions for biopsy chairs to measurable impacts on workflow and patient throughput. Integrated motorized features and memory‑preset positioning directly address clinician fatigue and reduce adjustments, which correlates with efficiency improvements in facilities performing hundreds of biopsies monthly. Early adopters in high‑volume breast imaging centers report reduced procedure times and fewer repositioning errors, particularly when paired with advanced 3D mammography systems, reinforcing technology‑led differentiation among competitors.
• Clinically, the emphasis on minimally invasive diagnosis and outpatient care has accelerated demand for ergonomic chairs that support diverse procedures and patient demographics. With nearly 70 % of women with abnormal mammograms proceeding to biopsy, expect equipment that enhances comfort and precision to increasingly factor into protocol design in both hospital and clinic settings.
• At an operational level, reimbursement environment and quality metrics shape procurement. In markets like the United States, where mammography and related diagnostic procedures form a sizeable portion of radiology claims, the chair’s performance in supporting rapid, accurate biopsies is tied to facility reputation and care outcomes. Firms that can demonstrate empirical benefits through clinical data and case studies will secure preferential positioning with integrated delivery networks and imaging service providers.

Market Segmentation

• By Product Type
  • Electric
  • Manual
• By Feature
  • Reclining
  • Non-Reclining
• By End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others (Cancer Research Institutes, etc.)
• By Region
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Wolverson X-Ray Limited
  • Univest-X
  • AKRUS GmbH & Co. KG
  • Z&Z Medical, Inc.
  • GF Health Products, Inc.
  • VELA Medical
  • Cone Instruments, LLC
  • Graham-Field Inc.
  • Medical Positioning, Inc.
  • Medline Industries, Inc.
  • Champion Manufacturing Inc.
  • GE Healthcare

Sources

Primary Research interviews

• Radiologists and breast imaging specialists from leading hospitals
• Technicians and nursing staff operating biopsy chairs
• Procurement managers from diagnostic imaging centers
• Outpatient and specialty breast care clinic administrators

Databases

• PubMed
• ClinicalTrials.gov
• WHO Global Health Observatory
• NIH Research Portfolio Online Reporting Tools (RePORT)

Magazines

• Radiology Today
• AuntMinnie.com
• Diagnostic Imaging Magazine
• Health Imaging

Journals

• Journal of Breast Imaging
• European Journal of Radiology
• The Breast Journal
• Academic Radiology

Newspapers

• The New York Times – Health Section
• The Guardian – Health and Science
• The Washington Post – Health
• Japan Times – Medical News

Associations

• American College of Radiology (ACR)
• Society of Breast Imaging (SBI)
• European Society of Breast Imaging (EUSOBI)
• Japan Radiological Society (JRS)

Public Domain sources

• World Health Organization (WHO) reports
• Centers for Disease Control and Prevention (CDC) publications
• National Cancer Institute (NCI) statistics
• Government health ministry guidelines and reports

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years